Effect of coenzyme Q10 versus placebo on improving symptoms of autism spectrum disorder

Phase 2

• Conditions: Autism spectrum disorder.; Autistic disorder; F84.0

• Registration Number: IRCT20120215009014N330
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Age of 6 to 12 years,
Autism spectrum disorder

Exclusion Criteria

Taking antioxidant and anti-inflammatory drugs over the past month,
Drug intolerance

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptoms of autism. Timepoint: Before the intervention and 8 weeks after that. Method of measurement: By using the standard questionnaire of Childhood Autism Rating Scale (CARS).